海思科(002653.SZ):拟在新加坡设立全资孙公司
格隆汇3月24日丨海思科(002653.SZ)公布,公司第三届董事会第五十次会议审议通过了《关于在新加坡设立全资孙公司的议案》,同意公司全资子公司四川海思科制药有限公司(“四川海思科”)以自有资金1000万美元在新加坡出资设立全资子公司Haisco Holdings PTE.LTD.。
公司在新加坡设立全资孙公司是考虑利用新加坡的政策、技术等优势推进海外开展临床研究,加快公司的国际化进程,提升公司海外市场影响力。上述孙公司尚处于设立阶段,短期内不会对公司的业绩产生实质性影响。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.